Search

Read about the latest findings in immunotherapy from the 2021 annual meeting of the American Society of Clinical Oncology (ASCO).

… Monday, June 7, 2021 Memorial Sloan Kettering researchers presented more than 100 studies at the 2021 American Society of Clinical Oncology (ASCO) annual meeting, held virtually again this year. In case you missed it, here are a few related to immunotherapy that caught our eye. Also from the 2021 ASCO

The lack of participation in clinical research may be the Achilles’ heel of today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of Memorial Sloan Kettering Cancer Center (MSK), only 35 percent of Americans indicated that they were “likely” to enroll in a clinical trial. Other studies have shown that only 4 percent of cancer patients enroll in clinical trials nationally each year.

… Monday, May 23, 2016 The lack of participation in clinical research may be the Achilles’ heel of today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of Memorial Sloan Kettering Cancer Center (MSK), only 35 percent of Americans

A study from MSK takes a deeper look at some of the causes of secondary leukemia.

… Monday, September 9, 2019 Summary A new study from Memorial Sloan Kettering suggests that in some people treated for breast cancer, leukemia-causing gene mutations may be present in blood cells from the time the original cancer was diagnosed. This helps explain some cases of secondary leukemia. Doctors

it means to survive cancer and learn how MSK is honoring all cancer survivors this year during National Cancer Survivor Month.

… Wednesday, June 17, 2020 Seth Frankel sitting in a red chair “Being a cancer survivor is a little bit like being a superhero: Not everyone will know your secret identity, but you have an ability to summon a hidden strength that can overcome any obstacle standing in your way.” — Seth Frankel, age 39,

Martin S. Tallman, MD, has been appointed Chief of the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College.

… Tuesday, May 11, 2010 Martin S. Tallman, MD, has been appointed Chief of the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College. “We are very fortunate to have Dr. Tallman join the Memorial Sloan Kettering

Dr. Andy Minn, the inaugural chair of MSK's Immuno-Oncology Program, discusses his vision for the program and what it means for patients.

… Wednesday, October 15, 2025 A revolution is underway in oncology, and in medicine more broadly. Immunotherapies are marshalling the power of the human immune system against cancer to augment or even sometimes replace traditional treatments — and they are starting to make inroads against autoimmune diseases

… Monday, May 23, 2022 You sometimes hear the steady beat of the drum before you see the boat. An imposing figure then comes into view, slicing through the water. It’s a multicolor 40-foot canoe. Finally, you hear the paddlers’ yells of encouragement: “Come on, faster. We can do this!” Welcome to dragon

A recent study from MSK investigators found that most patients who received genetic counseling by telemedicine during the early months of the pandemic reported being highly satisfied with the care they received.

… Wednesday, December 15, 2021 Sometimes a physical exam is a critical part of a healthcare visit. But patients are learning that for many medical appointments, a telemedicine visit can be just as valuable. Some people even prefer telemedicine, because they find speaking with a healthcare provider from

A multidisciplinary team of Memorial Sloan Kettering investigators has shown for the first time that the gene that causes the inherited form of Parkinson's disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common form of brain cancer.

… Monday, February 1, 2010 Summary A multidisciplinary team of Memorial Sloan Kettering investigators has shown for the first time that the gene that causes the inherited form of Parkinson’s disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common

New drugs are being developed that target part of the process to make proteins.

… Wednesday, July 18, 2018 Summary Research into how proteins are made is being used for a possible new treatment for blood cancers. Cancer is a disease of the genes. But genes don’t directly cause the uncontrolled cell growth that characterizes the disease — proteins produced by those genes do. Consequently